Treatment of Urinary Tract Tuberculosis: Evidence-Based Protocol

Urinary tract tuberculosis (ICD-11 1B12.5) is an extrapulmonary manifestation of tuberculosis affecting the urinary organs. Treatment follows a structured pharmacological approach directed by evidence-based guidelines.

Treatment Approach

The standard regimen is a two-phase oral pharmacological course — an intensive initial combination phase followed by a consolidation maintenance phase with fewer agents.

Drug selection, weight-based dosing, phase durations, and the complete regimen are detailed in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1590/S1677-5538.IBJU.2024.0590

The treatment of UGT comprises two phases (Table-2): an intensive (or attack) phase with rifampicin, isoniazid, pyrazinamide and ethambutol that lasts for two months and a maintenance phase with rifampicin and isoniazid that lasts for months (GRADE: high, strong).

In Brazil, the basic regimen for tuberculosis treatment consists of four drugs in the intensive phase (rifampicin, isoniazid, pyrazinamide and ethambutol), which lasts 2 months, and two drugs (rifampicin and isoniazid, which have greater bactericidal power) in the maintenance phase, which lasts 4 months.

View source ↗